RxDoctor Payments Data

Sandi Engler, PA

Physician Assistant · Summerville, SCNPI 1588643860

Payments from drug & device makers

$6,696in general payments, 2019–2025

Across 364 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$791
  • AstraZeneca$639
  • Sanofi-aventis U.S. LLC$419
  • Takeda Pharmaceuticals U.S.A., Inc.$339
  • GSK$333
  • Lilly USA, LLC$267
  • plus $4K from 51 others

What the payments were for

  • Food & beverage$6,696100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie59$791
AstraZeneca34$639
Sanofi-aventis U.S. LLC20$419
Takeda Pharmaceuticals U.S.A., Inc.14$339
GSK20$333
Lilly USA, LLC15$267
Supernus Pharmaceuticals, Inc.7$256
Novo Nordisk16$252
Otsuka America Pharmaceutical, Inc.13$239
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$218
Novartis12$217
Pfizer11$210
Bayer10$189
Johnson & Johnson13$189
Sumitomo Pharma America, Inc.5$142
Lundbeck LLC6$140
Amgen8$134
Sunovion Pharmaceuticals Inc.6$125
Boehringer Ingelheim7$121
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$112
Esperion Therapeutics, Inc.7$97
Merck6$93
Dexcom, Inc.3$88
Exact Sciences5$85
Xeris Pharmaceuticals, Inc.3$65
Phathom Pharmaceuticals, Inc.3$64
Abbott2$61
Medtronic3$58
Corium, LLC3$56
Boston Scientific2$55
Jazz Pharmaceuticals Inc.2$47
Astellas Pharma US Inc2$47
Eisai Inc.3$39
Regeneron Healthcare Solutions, Inc.2$39
Acadia Pharmaceuticals Inc2$36
Axonics, Inc.1$32
Antares Pharma, Inc.2$29
Intuity Medical Inc1$26
Acerus Pharmaceuticals Corporation2$26
Gilead1$24
Ironwood Pharmaceuticals, Inc1$24
Urovant Sciences Inc1$24
Axsome Therapeutics, Inc.1$23
Philips North America LLC1$23
Idorsia Pharmaceuticals US Inc1$21
Ultragenyx Pharmaceutical Inc.1$20
Viatris Specialty LLC1$19
Nestle Healthcare Nutrition Inc.1$19
Renalytix AI, Inc.1$16
Biohaven Pharmaceuticals, Inc.1$16
Almatica Pharma LLC1$15
Biohaven Pharmaceutical Holding Company Ltd.1$15
Biodelivery Sciences International, Inc.1$15
Avanir Pharmaceuticals, Inc.1$15
Mylan Specialty L.p.1$14
VBI Vaccine (delaware) Inc.1$13
Genentech USA, Inc.1$12

How this compares

$6,696 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$102,797
Medicare patients
306
Services billed
2,102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide105$141,388
JardianceEmpagliflozin83$87,443
FarxigaDapagliflozin Propanediol80$75,659
EliquisApixaban57$75,179
MounjaroTirzepatide49$62,838
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$51,888
JanuviaSitagliptin Phosphate31$38,128
LinzessLinaclotide29$33,263
EntrestoSacubitril/Valsartan13$25,931
RybelsusSemaglutide13$22,166
TrulicityDulaglutide18$19,112
MyrbetriqMirabegron29$18,673
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$14,957
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$14,906
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$14,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$252$163,553118 claims
Boehringer IngelheimJardiance, Stiolto Respimat$121$101,65399 claims
AstraZenecaFarxiga, Symbicort$639$82,37193 claims
Lilly USA, LLCMounjaro, Trulicity$267$81,94967 claims
PfizerEliquis$210$75,17957 claims
GSKTrelegy Ellipta, Anoro Ellipta$333$66,79458 claims
MerckJanuvia$93$38,12831 claims
AbbVieLinzess, Synthroid$791$35,36167 claims
NovartisEntresto$217$25,93113 claims
Astellas Pharma US IncMyrbetriq$47$18,67329 claims
Johnson & JohnsonXarelto$189$13,63511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →